Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)

 
ACAD Technical Analysis
3
As on 1st Aug 2025 ACAD STOCK Price closed @ 23.53 and we RECOMMEND Buy for LONG-TERM with Stoploss of 17.24 & Buy for SHORT-TERM with Stoploss of 20.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACADSTOCK Price

Open 23.70 Change Price %
High 23.90 1 Day -0.30 -1.26
Low 23.25 1 Week 0.26 1.12
Close 23.53 1 Month 0.58 2.53
Volume 1750031 1 Year -2.03 -7.94
52 Week High 26.76 | 52 Week Low 14.10
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 173.72 -2.33%
OPEN 2.10 14.13%
EQ 0.71 82.05%
AMZN 214.75 -8.27%
NCNA 0.04 0.00%
LMDX 0.02 0.00%
BTAI 1.37 4.58%
AKTS 0.04 0.00%
AAPL 202.38 -2.50%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
HCTI 4.75 15733.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ORGS 1.00 1566.67%
REDU 3.41 1075.86%
DRMA 6.45 940.32%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
OTRKP 0.02 -60.00%
HEPA 0.05 -58.33%
 
 
ACAD
Daily Charts		 ACAD
Intraday Charts		 Whats New @
Bazaartrend		 ACAD
Free Analysis
 
ACAD Important Levels Intraday
RESISTANCE24.78
RESISTANCE24.38
RESISTANCE24.13
RESISTANCE23.88
SUPPORT23.18
SUPPORT22.93
SUPPORT22.68
SUPPORT22.28
 
ACAD Forecast August 2025
Share
4th UP Forecast40.87
3rd UP Forecast35.31
2nd UP Forecast31.87
1st UP Forecast28.44
1st DOWN Forecast18.63
2nd DOWN Forecast15.19
3rd DOWN Forecast11.75
4th DOWN Forecast6.19
 
ACAD Weekly Forecast
4th UP Forecast30.43
3rd UP Forecast28.22
2nd UP Forecast26.85
1st UP Forecast25.48
1st DOWN Forecast21.58
2nd DOWN Forecast20.21
3rd DOWN Forecast18.84
4th DOWN Forecast16.63
 
ACAD Forecast2025
4th UP Forecast48.89
3rd UP Forecast40.76
2nd UP Forecast35.73
1st UP Forecast30.7
1st DOWN Forecast16.36
2nd DOWN Forecast11.33
3rd DOWN Forecast6.3
4th DOWN Forecast-1.83
 
 
ACAD Other Details
Segment EQ
Market Capital 2922096384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACAD Address
ACAD
 
ACAD Latest News
 
Your Comments and Response on ACADIA Pharmaceuticals Inc
 
ACAD Business Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Address: 12830 El Camino Real, San Diego, CA, United States, 92130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service